Document Detail


How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
MedLine Citation:
PMID:  22247448     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Over the last decade, advances in diagnostic systems and the introduction of new antifungal agents have significantly improved outcomes in immunocompromised patients who develop invasive aspergillosis. However, mortality rates remain relatively unchanged for less common, but highly aggressive, mold infections such as mucormycosis. Recent genome sequencing of Rhizopus oryzae revealed evidence of a whole-genome duplication event during the evolution of this pathogen. Consequently, R. oryzae has a 2- to 10-fold enrichment in gene families associated with ergosterol and cell wall biosynthesis, cell growth, iron uptake, and known fungal virulence factors compared with sequenced Aspergillus fumigatus strains. This genetic plasticity may explain the remarkable capability of this pathogen for rapid growth in hostile environments, such as the inflammatory milieu, as well as its relative resistance to multiple antifungal classes. Herein, we examine how pharmacological aspects of treating mucormycosis may differ from those of the more commonly encountered invasive aspergillosis.
Authors:
Russell E Lewis; Olivier Lortholary; Brad Spellberg; Emmanuel Roilides; Dimitrios P Kontoyiannis; Thomas J Walsh
Related Documents :
7873598 - Cloning and expression of the gene of hemocytin, an insect humoral lectin which is homo...
10343118 - Cdna cloning, characterization, and chromosome mapping of ube2e3 (alias ubch9), encodin...
2015948 - The partial sequencing of human nonspecific (bone/liver/kidney) alkaline phosphatase gene.
22160698 - Mature clustered, regularly interspaced, short palindromic repeats rna (crrna) length i...
11335018 - Plagiarized bacterial genes in the human book of life.
12219208 - The nucleotide sequence of gltd gene encoding the small subunit of rhodobacter sphaeroi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  54 Suppl 1     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-01-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S67-72     Citation Subset:  IM    
Affiliation:
Department of College of Pharmacy, The University of Houston, Texas.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Host defenses against zygomycetes.
Next Document:  Combination therapy for mucormycosis: why, what, and how?